(Press-News.org) ITHACA, N.Y. – An international collaboration led by Cornell University researchers used a combination of psilocybin and the rabies virus to map how – and where – the psychedelic compound rewires the connections in the brain.
Specifically, they showed psilocybin weakens the cortico-cortical feedback loops that can lock people into negative thinking. Psilocybin also strengthens pathways to subcortical regions that turn sensory perceptions into action, essentially enhancing sensory-motor responses.
The findings published Dec. 5 in Cell.
The project is the latest by Alex Kwan, professor of biomedical engineering and the paper’s senior author. Kwan’s lab studies the ways psychiatric drugs such as psilocybin, ketamine and 5-MeO-DMT rewire the brain’s neurological circuitry, with the goal of developing therapeutic treatments for depression.
Psilocybin, which is the active ingredient in magic mushrooms, is a promising candidate for pharmaceutical development because the clinical trials has shown that the psychedelic drug can reduce symptoms in people with depression – for weeks and perhaps even months after a single treatment.
“With psilocybin, it’s like we’re adding all these roads to the brain, but we don’t know where the roads go,” Kwan said. “Here we use the rabies virus to read out the connectivity in the brain, because these viruses are engineered in nature to transmit between neurons. That’s how they’re so deadly. It jumps a synapse and goes from one neuron to another.”
The researchers saw that the sensory area of the brain becomes more strongly wired to the subcortical region, strengthening the link between perception and action.
Initially Kwan expected to find connections between one or two regions of the brain, but he was surprised to discover psilocybin’s rewiring involved the whole brain.
“This is really looking at brain-wide changes,” he said. “That’s a scale that we have not worked at before. A lot of times, we’re focusing on a small part of the neural circuit.”
The extensive pathway mapping also showed that the amount of firing activity in the brain may determine what gets rewired by the drug. That inspired the researchers to demonstrate that by perturbing and manipulating the neural activity of one brain region, they could actually change the way psilocybin rewires the circuitry.
“That opens up many possibilities for therapeutics, how you maybe avoid some of the plasticity that’s negative and then enhance specifically those that are positive,” Kwan said.
The research was supported by One Mind and the National Institutes of Health.
For additional information, see this Cornell Chronicle story.
Cornell University has dedicated television and audio studios available for media interviews.
-30-
END
Dose of psilocybin, dash of rabies point to treatment for depression
2025-12-05
ELSE PRESS RELEASES FROM THIS DATE:
Helping health care providers navigate social, political, and legal barriers to patient care
2025-12-05
In November, The Lancet, one of the world’s most esteemed medical journals, launched a new monthly series of case studies that goes beyond clinical diagnoses to illuminate the social and cultural forces that contribute to each patient’s condition.
Clinical case studies have long been a fixture in medical journals and are a primary way doctors and other health professionals continue learning after their initial training. Typically, case studies are short summaries of a patient’s predicament alongside a clinician’s assessment, diagnosis, ...
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
2025-12-05
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
Advises that injectable treatments must be offered, reducing reliance on opioids
PHOENIX – A new study by Phoenix’s Barrow Neurological Institute and the University of Calgary has found which injectable treatments showed the most benefit for migraine patients and should be routinely offered by Emergency Departments (ED) when feasible. The findings from the study will update the guidelines for the American Headache Society.
Based on a systematic review of clinical trial data, the study ...
Using smartphones to improve disaster search and rescue
2025-12-05
HONOLULU, Dec. 5, 2025 — When a natural disaster strikes, time is of the essence if people are trapped under rubble. Conventional search-and-rescue methods use radar-based detection or employ acoustics that rely on sounds made by victims.
Since most people carry their phones with them every day, Shogo Takada, a student at the University of Tokyo, is working on a way to use smartphone microphones to assist in locating disaster victims.
Takada will present his results Friday, Dec. 5, at 11:45 a.m. HST as part of the Sixth Joint Meeting of the Acoustical Society of America and Acoustical Society of Japan, running Dec. 1-5 in Honolulu, ...
Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing
2025-12-05
A new study highlights a promising path toward sustainable hydrogen peroxide production using sunlight, oxygen, and water, offering a cleaner alternative to the energy-intensive anthraquinone process that dominates global manufacturing today.
In a commentary published in Sustainable Carbon Materials, researchers Bing Han of North China Electric Power University and Yin Zhang of Nanyang Technological University discuss a recent advancement in covalent organic framework technologies that could reshape photocatalytic chemical synthesis. The featured work, led by Yang and colleagues, demonstrates how a rational redesign of catalyst structures can dramatically boost the efficiency ...
Ultrafast material captures toxic PFAS at record speed and capacity
2025-12-05
Researchers have developed a new material that captures harmful PFAS chemicals from water in a matter of seconds, offering a promising pathway to address one of today’s most persistent environmental threats. The study reports that a nitrate-intercalated layered double hydroxide can remove perfluorooctanoic acid, a widely detected PFAS contaminant, with an exceptional capacity of 1,702 milligrams per gram.
PFAS, often called forever chemicals because of their extreme persistence, are commonly found in drinking water, soils, and even human blood. Traditional adsorbents such as activated carbon and biochar often struggle with limited ...
Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
2025-12-05
Plant derived phenolic acids can dramatically enhance the activity of existing antibiotics against multidrug resistant E. coli, offering a promising new tool in the global fight against antimicrobial resistance. In laboratory and insect models, these natural compounds helped an older antibiotic kill resistant bacteria more efficiently and reduced the chance that new resistance would emerge.
“Instead of waiting many years and spending enormous resources to develop brand new antibiotics, we show that small molecules already present in plants can breathe new life into the drugs we rely on today,” ...
UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections
2025-12-05
A new study from UNC-Chapel Hill researchers shows that advanced artificial intelligence tools, specifically large language models (LLMs), can accurately determine the locations where plant specimens were originally collected, a process known as georeferencing. This task has traditionally been slow, expensive and dependent on significant manual effort. The team found that LLMs can complete this work with near-human accuracy while being significantly faster and more cost-effective.
“Our ...
OYE Therapeutics closes $5M convertible note round, advancing toward clinical development
2025-12-05
CROWN POINT, Ind. — OYE Therapeutics Inc., a privately held biopharmaceutical company developing first-in-class intravenous caffeine-based therapies for anesthesia recovery and opioid-induced respiratory depression, has announced the successful close of its $5 million convertible note financing, positioning the company to enter clinical development.
The company is headquartered at the Purdue Technology Center of Northwest Indiana.
CEO Brett Dines said the round drew strong new investor participation and was oversubscribed to $5.6 million, reflecting sustained confidence ...
Membrane ‘neighborhood’ helps transporter protein regulate cell signaling
2025-12-05
(MEMPHIS, Tenn. – December 5, 2025) When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ensure the signal reaches the correct effector without triggering pathways accidentally, cAMP levels must be maintained around their point of origin and at the right level. ABCC4, a protein that transports cAMP out of cells and also contributes to drug resistance, helps with this local control. Yet, how ABCC4 is held in place at the right spot to perform these functions was not clear. Scientists at St. Jude Children’s Research Hospital revealed that global elevation ...
Naval aviator turned NPS doctoral student earns national recognition for applied quantum research
2025-12-05
A Naval Postgraduate School (NPS) physics doctoral student has just been presented with a prestigious award for his pioneering research in quantum sensing using a unique atomic fountain.
U.S. Navy Cmdr. Jens Berdahl, a former naval aviator and F/A-18 pilot currently pursuing his doctorate through the service’s Permanent Military Professor (PMP) program, was recently presented with the highly competitive Margaret Burbidge Award for Best Experimental Research by a Graduate Student. Presented by the American Physical Society, Far West Section, Berdahl received the award while presenting his research on NPS’s ...